Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor "knockouts": Identification of D4:D1-like interactions

Synapse

Volumn 59, Issue 2, 2006, Pages 107-118

  O'Sullivan, Gerard J ^a   Kinsella, Anthony ^b   Grandy, David K ^c   Tighe, Orna ^a   Croke, David T ^a   Waddington, John L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

D4 knockout mice; Dopamine receptor subtypes; Ethogram; Grooming behavior; Seizures

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; ADENYLATE CYCLASE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; N (3 HYDROXYPHENETHYL) N (PHENETHYL)PROPYLAMINE; PHOSPHOLIPASE C; SKF 83822; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENIC STRAIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GROOMING; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SNIFFING; STEREOTYPY;

ADENYLATE CYCLASE; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE AGONISTS; MICE; MICE, KNOCKOUT; PHOSPHOLIPASE C; RECEPTORS, DOPAMINE;

EID: 30144433610     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20225     Document Type: Article

References (73)

1. Aldridge JW, Berridge KC. 1998. Coding of serial order by neostriatal neurons: a "natural action" approach to movement sequence. J Neurosci 18:2777-2787.
2. Andersen PH, Jansen JA. 1990. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur J Pharmacol 188:335-347.
3. Andringa G, Drukarch B, Leysen JE, Cools AR, Stoof JC. 1999. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors. Eur J Pharmacol 364:33-41.
4. Arnt J, Hyttel J, Sanchez C. 1992. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213:259-267.
5. Banbury Conference. 1997. Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice. Neuron 19:755-759.
6. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. 1996. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet 12:81-84.
7. Clifford JJ, Waddington JL. 2000. Topographically based search for an "ethogram" among a series of novel D(4) dopamine receptor agonists and antagonists. Neuropsychopharmacology 22:538-544.
8. Clifford JJ, Tighe O, Croke DT, Sibley DR, Drago J, Waddington JL. 1998. Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology 37:1595-1602.
9. Clifford JJ, Tighe O, Croke DT, Kinsella A, Sibley DR, Drago J, Waddington JL. 1999. Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase. Neuroscience 93:1483-1489.
10. Clifford JJ, Usiello A, Vallone D, Kinsella A, Borrelli E, Waddington JL. 2000. Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor. Neuropharmacology 39:382-390.
11. Clifford JJ, Kinsella A, Tighe O, Rubinstein M, Grandy DK, Low MJ, Croke DT, Waddington JL. 2001. Comparative, topographically-based evaluation of behavioural phenotype and specification of D(1)-like:D(2) interactions in a line of incipient congenic mice with D(2) dopamine receptor 'knockout'. Neuropsychopharmacology 25:527-536.
12. Clifford JJ, Drago J, Natoli AL, Wong JY, Kinsella A, Waddington JL, Vaddadi KS. 2002. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease. Neuroscience 109:81-88.
13. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R. 1997. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132:107-124.
14. Daly SA, Waddington JL. 1993. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C. Psychopharmacology 113:45-50.
15. DeNinno MP, Schoenleber R, MacKenzie R, Britton DR, Asin KE, Briggs C, Trugman JM, Ackerman M, Artman L, Bednarz L, Bhatt R, Curzon P, Gomez E, Kang CH, Stittsworth J, Kebabian JW. 1991. A68930: a potent agonist selective for the dopamine D1 receptor. Eur J Pharmacol 199:209-219.
16. Deveney AM, Waddington JL. 1995. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 116:2120-2126.
17. Dulawa SC, Grandy DK, Low MJ, Paulus MP, Geyer MA. 1999. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci 19:9550-9556.
18. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH. 1996. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 12:78-80.
19. Ekelund J, Suhonen J, Jarvelin MR, Peltonen L, Lichtermann D. 2001. No association of the -521 C/T polymorphism in the promoter of DRD4 with novelty seeking. Mol Psychiatry 6:618-619.
20. Falzone TL, Gelman DM, Young JI, Grandy DK, Low MJ, Rubinstein M. 2002. Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear. Eur J Neurosci 15:158-164.
21. Ferraro TN, Golden GT, Smith GG, St Jean P, Schork NJ, Mulholland N, Ballas C, Schill J, Buono RJ, Berrettini WH. 1999. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J Neurosci 19:6733-6739.
22. Fishburn CS, Carmon S, Fuchs S. 1995. Molecular cloning and characterisation of the gene encoding the murine D4 dopamine receptor. FEBS Lett 361:215-219.
23. Gan L, Falzone TL, Zhang K, Rubinstein M, Ldessarini RJ, Tarazi FI. 2004. Enhanced expression of dopamine D1 and glutamate NMDA receptors in dopamine D4 receptor knockout mice. J Mol Neurosci 22:167-178.
24. Gingrich JA, Hen R. 2000. The broken mouse: the role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice. Curr Opin Neurobiol 10:146-152.
25. Helmeste DM, Tang SW. 2000. Dopamine D4 receptors. Jpn J Pharmacol 82:1-14.
26. Jin LQ, Goswami S, Cai G, Zhen X, Friedman E. 2003. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain. J Neurochem 85:378-386.
27. Jonsson EG, Sedvall GC, Nothen MM, Cichon S. 2003. Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses. Schizophr Res 61:111-119.
28. Katz JL, Chausmer AL, Elmer GI, Rubinstein M, Low MJ, Grandy DK. 2003. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D4 receptor mutant mice. Psychopharmacology 170:108-114.
29. Kebabian JW, Britton DR, DeNinno MP, Ferner R, Smith L, Jenner P, Schoenleber R, Williams M. 1992. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Eur J Pharmacol 229:203-209.
30. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G, Bunzow JR, Fang Y, Gerhardt GA, Grandy DK, Low MJ. 1998. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18:3470-3479.
31. Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Fujita K, Kreitman RJ, Pastan I, Nagatsu T. 1995. Immunotoxin-mediated conditional disruption of specific neurons in transgenic mice. Proc Natl Acad Sci USA 92:1132-1136.
32. Kruzich PJ, Suchland KL, Grandy DK. 2004. Dopamine D4 receptor-deficient mice, congenic on the C57BL/6J background, are hypersensitive to amphetamine. Synapse 53:131-139.
33. Lee SP, O'Dowd BF, George SR. 2003. Homo- and hetero-oligomerization of G protein-coupled receptors. Life Sci 74:173-180.
34. McKhann GM, Wenzel HJ, Robbins CA, Sosunov AA, Schwartzkroin PA. 2003. Mouse strain differences in kainic acid sensitivity, seizure behavior, mortality, and hippocampal pathology. Neuroscience 122:551-561.
35. McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Fuchs S, Croke DT, Waddington JL. 2002. Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout." Synapse 46:19-31.
36. McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Croke DT, Waddington JL. 2003. Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype. Neuropsychopharmacology 28:86-99.
37. Meyer-Luehmann M, Thompson JF, Berridge KC, Aldridge JW. 2002. Substantia nigra pars reticulata neurons code initiation of a serial pattern: implications for natural action sequences and sequential disorders. Eur J Neurosci 16:1599-1608.
38. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
39. Molloy AG, Waddington JL. 1984. Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology 82:409-410.
40. Montkowski A, Poettig M, Mederer A, Holsboer F. 1997. Behavioural performance in three substrains of mouse strain 129. Brain Res 762:12-18.
41. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. 1996. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381:245-248.
42. Muglia P, Petronis A, Mundo E, Lander S, Cate T, Kennedy JL. 2002. Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4. Mol Psychiatry 7:860-866.
43. Nally RE, McNamara FN, Clifford JJ, Kinsella A, Tighe O, Croke DT, Fienberg AA, Greengard P, Waddington JL. 2003. Topographical assessment of ethological and dopamine receptor agonist-induced behavioral phenotype in mutants with congenic DARPP-32 'knockout'. Neuropsychopharmacology 28:2055-2063.
44. Nally RE, Kinsella A, Tighe O, Crake DT, Fienberg AA, Greengard P, Waddington JL. 2004. Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3′,5′-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57B176 genetic background. J Pharmacol Exp Ther 310:1281-1287.
45. Nir I, Harrison JM, Haque R, Low MJ, Grandy DK, Rubinstein M, Iuvone PM. 2002. Dysfunctional light-evoked regulation of cAMP in photoreceptors and abnormal retinal adaptation in mice lacking dopamine D4 receptors. J Neurosci 22:2063-2073.
46. Niznik HB, Sugamori KS, Clifford JJ, Waddington JL. 2002. D1-like dopamine receptors: molecular biology and pharmacology. In: Di Chiara G, editor. Handbook of Experimental Pharmacology: Dopamine in the CNS. Heidelberg: Springer. p 121-158.
47. Oak JN, Oldenhof J, Van Tol HH. 2000. The dopamine D(4) receptor: one decade of research. Eur J Pharmacol 405:303-327.
48. O'Sullivan GJ, Roth BL, Kinsella A, Waddington JL. 2004. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography. Eur J Pharmacol 486:273-280.
49. O'Sullivan GJ, Kinsella A, Sibley DR, Tighe O, Croke DT, Waddington JL. 2005. Ethological resolution of behavioural topography and D(1)-like versus D(2)-like agonist responses in congenic D(5) dopamine receptor mutants: identification of D(5):D(2)-like interactions. Synapse 55:201-211.
50. Panchalingam S, Undie AS. 2001. SKF83959 exhibits biochemical agonism by stimulating [(35)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain. Neuropharmacology 40:826-837.
51. Paterson AD, Sunohara GA, Kennedy JL. 1999. Dopamine D4 receptor gene: novelty or nonsense? Neuropsychopharmacology 21:3-16.
52. Peacock L, Gerlach J. 2001. Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions. Biol Psychiatry 50:501-509.
53. Ralph RJ, Varty GB, Kelly MA, Wang YM, Caron MG, Rubinstein M, Grandy DK, Low MJ, Geyer MA. 1999. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci 19:4627-4633.
54. Rivera A, Cuellar B, Giron FJ, Grandy DK, de la Calle A, Moratalla R. 2002. Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J Neurochem 80:219-229.
55. Rivera A, Trias S, Penafiel A, Angel Narvaez J, Diaz-Cabiale Z, Moratalla R, de la Calle A. 2003. Expression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum. Brain Res 989:35-41.
56. Rosengarten H, Friedhoff AJ. 1998. A phosphoinositide-linked dopamine D1 receptor mediates repetitive jaw movements in rats. Biol Psychiatry 44:1178-1184.
57. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB. 2002. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99:11934-11939.
58. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA, Saez C, Pugsley TA, Gershanik O, Low MJ, Grandy DK. 1997. Mice lacking dopamme D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90:991-1001.
59. Rubinstein M, Cepeda C, Hurst RS, Flores-Hernandez J, Ariano MA, Falzone TL, Kozell LB, Meshul CK, Bunzow JR, Low MJ, Levine MS, Grandy DK. 2001. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci 21:3756-3763.
60. Shin RM, Masuda M, Miura M, Sano H, Shirasawa T, Song WJ, Kobayashi K, Aosaki T. 2003. Dopamine D4 receptor-induced post-synaptic inhibition of GABAergic currents in mouse globus pallidus neurons. J Neurosci 23:11662-11672.
61. Sidhu A, Laruelle M, Vernier P. 2003. Dopamine Receptors and Transporters: Function, Imaging and Clinical Application. New York: Marcel Dekker.
62. Strobel A, Spinath FM, Angleitner A, Riemann R, Lesch KP. 2003. Lack of association between polymorphisms of the dopamine D4 receptor gene and personality. Neuropsychobiology 47:52-56.
63. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, Lerner M, Williams L, LaHoste GJ, Wigal S. 1998. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 3:38-41.
64. Tarazi FI, Baldessarini RJ. 1999. Brain dopamine D(4) receptors: basic and clinical status. Int J Neuropsychopharmacol 2:41-58.
65. Undie AS, Friedman E. 1994. Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices. J Neurochem 63:222-230.
66. Undie AS, Weinstock J, Sarau HM, Friedman E. 1994. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 62:2045-2048.
67. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. 1991. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614.
68. Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V. 1992. Multiple dopamine D4 receptor variants in the human population. Nature 358:149-152.
69. Waddington JL, Daly SA, McCauley PG, O'Boyle KM, 1994. Levels of functional interaction between D1-like and D2-like dopamine receptor systems. In:Niznik HB, editor. Dopamine Receptors and Transporters: Pharmacology, Structure and Function. New York: Marcel Dekker. p 511-537.
70. Waddington JL, Daly SA, Downes RP, Deveney AM, McCauley PG, O'Boyle KM. 1995. Behavioural pharmacology of 'D-1-like' dopamine receptors: further Subtyping, new pharmacological probes and interactions with 'D-2-like' receptors. Prog Neuropsychopharmacol Biol Psychiatry 19:811-831.
71. Waddington JL, Clifford JJ, McNamara FN, Tomiyama K, Koshikawa N, Croke DT. 2001. The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout'). Prog Neuropsychopharmacol Biol Psychiatry 25:925-964.
72. Wong AH, Van Tol HH. 2003. The dopamine D4 receptors and mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27:1091-1099.
73. Xing QH, Wu SN, Lin ZG, Li HF, Yang JD, Feng GY, Wang MT, Yang WW, He L. 2003. Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene in schizophrenia. Schizophr Res 65:9-14.